Burning Rock Biotech Limited BNR
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.67% | 83.99% | 71.61% | 75.16% | 59.81% |
| Total Depreciation and Amortization | -57.30% | -57.30% | -60.76% | -60.76% | -60.76% |
| Total Amortization of Deferred Charges | -82.92% | -82.92% | -58.12% | -58.12% | -58.12% |
| Total Other Non-Cash Items | -56.65% | -72.27% | -66.30% | -86.52% | -54.95% |
| Change in Net Operating Assets | -64.96% | -64.96% | 29.70% | 29.70% | 29.70% |
| Cash from Operations | 53.85% | 70.14% | 74.97% | 45.28% | 59.28% |
| Capital Expenditure | 1.71% | 1.71% | 32.88% | 32.88% | 32.88% |
| Sale of Property, Plant, and Equipment | -44.39% | -44.39% | 1,775.86% | 1,775.86% | 1,775.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 285.42% | 110.94% | -125.33% | -75.89% | 5.37% |
| Cash from Investing | 8.06% | 0.59% | -24.08% | 36.66% | 53.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 98.97% | 98.97% | 98.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -60.59% | 104.90% | 100.00% |
| Cash from Financing | 2,725.00% | 2,725.00% | 200.83% | 104.04% | 99.85% |
| Foreign Exchange rate Adjustments | -441.95% | -380.45% | 176.75% | 174.41% | -57.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.99% | 56.67% | 77.81% | 61.02% | 67.67% |